OMNI CRS survey shows recruitment challenges often surface too late, pointing to a need for earlier, more targeted patient engagement
STIRLING, NJ, March 30, 2026 /24-7PressRelease/ -- OMNI CRS is proud to present its inaugural Clinical Research Industry Survey, capturing insights from CROs, site networks, and independent research sites on the realities of patient recruitment in clinical trials. By capturing frontline insights from across the clinical research ecosystem, this survey establishes a baseline for tracking trends year over year.
Findings reveal a clear pattern: recruitment challenges rarely appear suddenly, and often surface only after timelines are already at risk. Survey data shows 75% of respondents identified lagging enrollment pace as the first signal of a problem, followed by 33% citing an increase in screener failure rates. Fifty percent (50%) cited faster access to qualified patients as the most meaningful improvement needed, followed by 22% citing less operational burden. These aligned insights underscore the need for earlier, protocol-specific patient engagement to improve start-up predictability and enrollment outcomes.
These findings point to a structural issue in how recruitment is approached. Challenges are not driven by lack of effort, capacity, or budget, but by delayed visibility into enrollment performance and misalignment between study criteria and real-world patient populations. By the time enrollment falls behind projections, sites are often limited to reactive measures, including increased ad spend and outreach, which may not address underlying issues.
Industry-wide, recruitment challenges are increasingly tied to broader operational pressures such as protocol complexity, study start-up delays, and staffing constraints. These factors are interconnected, reinforcing inefficiencies when recruitment strategies are not aligned early with study design and patient accessibility.
Survey responses further indicate that increasing spend and outreach volume alone is not sufficient. Instead, sites emphasized the need of accessing more qualified patients earlier in the process. High lead volume without corresponding eligibility leads to increased screening burden, budget strain, and continued pressure on timelines, often without improving enrollment outcomes.
Once a study is underway, addressing misalignment becomes more difficult due to protocol constraints, regulatory requirements, and ongoing operational demands. As a result, sites are often unable to correct course in time, reinforcing a reactive recruitment model.
OMNI CRS highlights that earlier, proactive engagement with qualified patients can significantly improve recruitment predictability. This approach provides faster feedback on whether enrollment strategies align with actual patient availability, reduces unnecessary screening, and supports higher conversion rates.
The company's model focuses on protocol-specific targeting, multichannel outreach across vetted health and medical media partners, and multi-level patient engagement & filtering designed to minimize unqualified inquiries. These combined methods enable earlier identification of enrollment challenges and more actionable data for both sites and sponsors.
Improving recruitment outcomes, OMNI CRS notes, depends less on increasing total investment and more on implementing responsive systems that identify and address misalignment early. By prioritizing early-stage signals and refining recruitment strategies in real time, clinical trials can shift from reactive enrollment management to a more predictable and sustainable model.
OMNI CRS is a patient enrollment partner supporting clinical trial sites, sponsors, and research organizations through targeted, data-informed outreach. Using a multichannel approach across a curated network of health and medical media partners, OMNI CRS emphasizes protocol-specific targeting, lead qualification, and continuous milestone-based optimization to improve the patient journey from referral to enrollment and reduce site burden across a wide range of therapeutic areas.
Website: https://omnicrs.com
---
Press release service and press release distribution provided by https://www.24-7pressrelease.com
